Cargando…

Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease

BACKGROUND: The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial failed to show a reduction in hard clinical end points with an early invasive strategy in stable ischemic heart disease (SIHD). However, the influence of left main disease an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bainey, Kevin R., Alemayehu, Wendimagegn, Welsh, Robert C., Kumar, Arnav, King, Spencer B., Kirtane, Ajay J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955498/
https://www.ncbi.nlm.nih.gov/pubmed/33342230
http://dx.doi.org/10.1161/JAHA.120.018104
_version_ 1783664265526247424
author Bainey, Kevin R.
Alemayehu, Wendimagegn
Welsh, Robert C.
Kumar, Arnav
King, Spencer B.
Kirtane, Ajay J.
author_facet Bainey, Kevin R.
Alemayehu, Wendimagegn
Welsh, Robert C.
Kumar, Arnav
King, Spencer B.
Kirtane, Ajay J.
author_sort Bainey, Kevin R.
collection PubMed
description BACKGROUND: The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial failed to show a reduction in hard clinical end points with an early invasive strategy in stable ischemic heart disease (SIHD). However, the influence of left main disease and high‐risk coronary anatomy was left unaddressed. In a large angiographic disease‐based registry, we examined the modulating effect of revascularization on long‐term outcomes in anatomically high‐risk SIHD. METHODS AND RESULTS: 9016 patients with SIHD with high‐risk coronary anatomy (3 vessel disease with ≥70% stenosis in all 3 epicardial vessels or left main disease ≥50% stenosis [isolated or in combination with other disease]) were selected for study from April 1, 2002 to March 31, 2016. The primary composite of all‐cause death or myocardial infarction (MI) was compared between revascularization versus conservative management. A total of 5487 (61.0%) patients received revascularization with either coronary artery bypass graft surgery (n=3312) or percutaneous coronary intervention (n=2175), while 3529 (39.0%) patients were managed conservatively. Selection for coronary revascularization was associated with improved all‐cause death/MI as well as longer survival compared with selection for conservative management (Inverse Probability Weighted hazard ratio [IPW‐HR] 0.62; 95% CI 0.58 to 0.66; P<0.001; IPW‐HR 0.57; 95% CI 0.53–0.61; P<0.001, respectively). Similar risk reduction was noted with percutaneous coronary intervention (IPW‐HR 0.64, 95% CI 0.59–0.70, P<0.001) and coronary artery bypass graft surgery (IPW‐HR 0.61; 95% CI 0.57–0.66; P<0.001). CONCLUSIONS: Revascularization in patients with SIHD with high‐risk coronary anatomy was associated with improved long‐term outcome compared with conservative therapy. As such, coronary anatomical profile should be considered when contemplating treatment for SIHD.
format Online
Article
Text
id pubmed-7955498
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79554982021-03-17 Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease Bainey, Kevin R. Alemayehu, Wendimagegn Welsh, Robert C. Kumar, Arnav King, Spencer B. Kirtane, Ajay J. J Am Heart Assoc Original Research BACKGROUND: The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial failed to show a reduction in hard clinical end points with an early invasive strategy in stable ischemic heart disease (SIHD). However, the influence of left main disease and high‐risk coronary anatomy was left unaddressed. In a large angiographic disease‐based registry, we examined the modulating effect of revascularization on long‐term outcomes in anatomically high‐risk SIHD. METHODS AND RESULTS: 9016 patients with SIHD with high‐risk coronary anatomy (3 vessel disease with ≥70% stenosis in all 3 epicardial vessels or left main disease ≥50% stenosis [isolated or in combination with other disease]) were selected for study from April 1, 2002 to March 31, 2016. The primary composite of all‐cause death or myocardial infarction (MI) was compared between revascularization versus conservative management. A total of 5487 (61.0%) patients received revascularization with either coronary artery bypass graft surgery (n=3312) or percutaneous coronary intervention (n=2175), while 3529 (39.0%) patients were managed conservatively. Selection for coronary revascularization was associated with improved all‐cause death/MI as well as longer survival compared with selection for conservative management (Inverse Probability Weighted hazard ratio [IPW‐HR] 0.62; 95% CI 0.58 to 0.66; P<0.001; IPW‐HR 0.57; 95% CI 0.53–0.61; P<0.001, respectively). Similar risk reduction was noted with percutaneous coronary intervention (IPW‐HR 0.64, 95% CI 0.59–0.70, P<0.001) and coronary artery bypass graft surgery (IPW‐HR 0.61; 95% CI 0.57–0.66; P<0.001). CONCLUSIONS: Revascularization in patients with SIHD with high‐risk coronary anatomy was associated with improved long‐term outcome compared with conservative therapy. As such, coronary anatomical profile should be considered when contemplating treatment for SIHD. John Wiley and Sons Inc. 2020-12-19 /pmc/articles/PMC7955498/ /pubmed/33342230 http://dx.doi.org/10.1161/JAHA.120.018104 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Bainey, Kevin R.
Alemayehu, Wendimagegn
Welsh, Robert C.
Kumar, Arnav
King, Spencer B.
Kirtane, Ajay J.
Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title_full Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title_fullStr Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title_full_unstemmed Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title_short Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
title_sort long‐term clinical outcomes following revascularization in high‐risk coronary anatomy patients with stable ischemic heart disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955498/
https://www.ncbi.nlm.nih.gov/pubmed/33342230
http://dx.doi.org/10.1161/JAHA.120.018104
work_keys_str_mv AT baineykevinr longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease
AT alemayehuwendimagegn longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease
AT welshrobertc longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease
AT kumararnav longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease
AT kingspencerb longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease
AT kirtaneajayj longtermclinicaloutcomesfollowingrevascularizationinhighriskcoronaryanatomypatientswithstableischemicheartdisease